Datasets:
SKT27182
/
NER_processed_data

Dataset card Viewer Files Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
sequence
ner_tags
sequence
NCT03145298
12:22:cancer,
History of malignancy within the last 5 years
1
[ "History", "of", "malignancy", "within", "the", "last", "5", "years" ]
[ 0, 0, 3, 0, 0, 0, 0, 0 ]
NCT02429934
22:33:chronic_disease
Subjects with active CNS disease
1
[ "Subjects", "with", "active", "CNS", "disease" ]
[ 0, 0, 0, 2, 2 ]
NCT02962557
34:63:chronic_disease
Patients with known or suspected obstructive sleep apnea (OSA)
1
[ "Patients", "with", "known", "or", "suspected", "obstructive", "sleep", "apnea", "(", "OSA", ")" ]
[ 0, 0, 0, 0, 0, 2, 2, 2, 2, 0, 0 ]
NCT02089607
1:18:chronic_disease
Innominate artery
1
[ "Innominate", "artery" ]
[ 2, 2 ]
NCT01972919
36:46:chronic_disease
Patients with and without regional adenopathy are eligible
1
[ "Patients", "with", "and", "without", "regional", "adenopathy", "are", "eligible" ]
[ 0, 0, 0, 0, 0, 2, 0, 0 ]
NCT02200445
18:48:treatment,
Received another investigational new drug (IND) within 5 half-lives of that agent before the planned commencement of SC IL-2
1
[ "Received", "another", "investigational", "new", "drug", "(", "IND", ")", "within", "5", "half-lives", "of", "that", "agent", "before", "the", "planned", "commencement", "of", "SC", "IL-2" ]
[ 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03038620
12:31:chronic_disease,33:47:chronic_disease,51:64:chronic_disease
History of gallbladder disease (cholelithiasis or cholecystitis)
1
[ "History", "of", "gallbladder", "disease", "(", "cholelithiasis", "or", "cholecystitis", ")" ]
[ 0, 0, 2, 2, 0, 2, 0, 2, 0 ]
NCT01697293
102:109:allergy_name,151:161:allergy_name,163:173:allergy_name
History of allergic reactions attributed to compounds of similar chemical or biologic composition to PTX-200 or other agents used in the study (e.g., imidazoles, quinolones)
1
[ "History", "of", "allergic", "reactions", "attributed", "to", "compounds", "of", "similar", "chemical", "or", "biologic", "composition", "to", "PTX-200", "or", "other", "agents", "used", "in", "the", "study", "(", "e.g.", ",", "imidazoles", ",", "quinolones", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 4, 0 ]
NCT03112603
1:8:treatment,20:25:chronic_disease,58:89:treatment,107:127:treatment,131:141:cancer
Steroid refractory cGvHD occurring after a non-scheduled donor lymphocyte infusion (DLI) administered for preemptive treatment of malignancy recurrence
1
[ "Steroid", "refractory", "cGvHD", "occurring", "after", "a", "non-scheduled", "donor", "lymphocyte", "infusion", "(", "DLI", ")", "administered", "for", "preemptive", "treatment", "of", "malignancy", "recurrence" ]
[ 1, 0, 2, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 1, 1, 0, 3, 0 ]
NCT02361554
15:37:chronic_disease
Subject has a neurological condition
1
[ "Subject", "has", "a", "neurological", "condition" ]
[ 0, 0, 0, 2, 2 ]
NCT01666769
23:64:treatment
Supported with either venoarterial (VA) or venovenous (VV) ECMO
1
[ "Supported", "with", "either", "venoarterial", "(", "VA", ")", "or", "venovenous", "(", "VV", ")", "ECMO" ]
[ 0, 0, 0, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0 ]
NCT02374021
1:16:treatment,,,
MTX monotherapy for ≥ 8 weeks at ≥ 15mg weekly or ≥ 7.5 mg weekly with a documented intolerance to higher doses
1
[ "MTX", "monotherapy", "for", "≥", "8", "weeks", "at", "≥", "15mg", "weekly", "or", "≥", "7.5", "mg", "weekly", "with", "a", "documented", "intolerance", "to", "higher", "doses" ]
[ 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02188121
62:71:treatment,,,
defined as entering one of the two-year First Episode Clinic treatment programs as a de novo patient (new disease) or having been diagnosed >2 years ago and had at least six visits in the past 12 months (prevalent disease)
1
[ "defined", "as", "entering", "one", "of", "the", "two-year", "First", "Episode", "Clinic", "treatment", "programs", "as", "a", "de", "novo", "patient", "(", "new", "disease", ")", "or", "having", "been", "diagnosed", ">", "2", "years", "ago", "and", "had", "at", "least", "six", "visits", "in", "the", "past", "12", "months", "(", "prevalent", "disease", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03059004
1:23:chronic_disease
Inflammatory arthritis
1
[ "Inflammatory", "arthritis" ]
[ 2, 2 ]
NCT02068092
29:49:treatment,58:67:treatment,85:91:cancer
Must not participate in any other clinical trial for the treatment or prevention of cancer unless they are no longer receiving the intervention and are in the follow-up phase only. Participants must also agree not to join such a trial while participating in this study
1
[ "Must", "not", "participate", "in", "any", "other", "clinical", "trial", "for", "the", "treatment", "or", "prevention", "of", "cancer", "unless", "they", "are", "no", "longer", "receiving", "the", "intervention", "and", "are", "in", "the", "follow-up", "phase", "only", ".", "Participants", "must", "also", "agree", "not", "to", "join", "such", "a", "trial", "while", "participating", "in", "this", "study" ]
[ 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 1, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02309580
12:46:treatment,52:66:treatment,68:78:treatment,,122:132:treatment
Concurrent systemic immunosuppressant therapy (eg, cyclosporine A, tacrolimus, etc.) within 28 days of the first dose of study drug
1
[ "Concurrent", "systemic", "immunosuppressant", "therapy", "(", "eg", ",", "cyclosporine", "A", ",", "tacrolimus", ",", "etc", ".", ")", "within", "28", "days", "of", "the", "first", "dose", "of", "study", "drug" ]
[ 0, 1, 1, 1, 0, 0, 0, 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02333162
40:48:treatment
Since these patients already had first allo-SCT
1
[ "Since", "these", "patients", "already", "had", "first", "allo-SCT" ]
[ 0, 0, 0, 0, 0, 0, 1 ]
NCT02128906
,,53:65:treatment
Pregnant women are excluded from this study because chemotherapy
1
[ "Pregnant", "women", "are", "excluded", "from", "this", "study", "because", "chemotherapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02844751
1:25:treatment,
Corticosteroid injection at treatment site within 1 month
1
[ "Corticosteroid", "injection", "at", "treatment", "site", "within", "1", "month" ]
[ 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT01795313
28:42:treatment,
Patients may have received re-irradiation but not to the index lesion within 4 weeks
1
[ "Patients", "may", "have", "received", "re-irradiation", "but", "not", "to", "the", "index", "lesion", "within", "4", "weeks" ]
[ 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01976429
26:38:chronic_disease
syndrome predisposing to otitis media
1
[ "syndrome", "predisposing", "to", "otitis", "media" ]
[ 0, 0, 0, 2, 2 ]
NCT02201992
108:124:chronic_disease,138:162:chronic_disease,164:188:chronic_disease,203:221:chronic_disease,226:263:chronic_disease
Patients must NOT have uncontrolled intercurrent illness including, but not limited to, serious ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, uncontrolled cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
1
[ "Patients", "must", "NOT", "have", "uncontrolled", "intercurrent", "illness", "including", ",", "but", "not", "limited", "to", ",", "serious", "ongoing", "or", "active", "infection", ",", "symptomatic", "congestive", "heart", "failure", ",", "unstable", "angina", "pectoris", ",", "uncontrolled", "cardiac", "arrhythmia", ",", "or", "psychiatric", "illness/social", "situations", "that", "would", "limit", "compliance", "with", "study", "requirements" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 2, 2, 2, 0, 2, 2, 2, 0, 0, 2, 2, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02355002
46:51:treatment,
Use of other psychotropic medications (e.g., SSRIs) will be allowed provided the dose has been stable for > 12 weeks
1
[ "Use", "of", "other", "psychotropic", "medications", "(", "e.g.", ",", "SSRIs", ")", "will", "be", "allowed", "provided", "the", "dose", "has", "been", "stable", "for", ">", "12", "weeks" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03011684
19:31:treatment
Has not yet begun chemotherapy
1
[ "Has", "not", "yet", "begun", "chemotherapy" ]
[ 0, 0, 0, 0, 1 ]
NCT02516696
,,,85:92:cancer
Subject has a Karnofsky performance status ≥60% (>50% if due to bony involvement of myeloma (see Appendix IV)
1
[ "Subject", "has", "a", "Karnofsky", "performance", "status", "≥60", "%", "(", ">", "50", "%", "if", "due", "to", "bony", "involvement", "of", "myeloma", "(", "see", "Appendix", "IV", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0 ]
NCT03093272
13:40:chronic_disease,
symptomatic peripheral vascular disease within 6 months prior to randomization
1
[ "symptomatic", "peripheral", "vascular", "disease", "within", "6", "months", "prior", "to", "randomization" ]
[ 0, 2, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT02016235
55:95:chronic_disease,97:112:chronic_disease,,,146:162:chronic_disease,181:199:treatment,201:216:treatment,221:230:treatment,
Exclusion criteria for calcium stone formers include: primary or secondary hyperparathyroidism, hyperthyroidism, estimated GFR <40 ml/mn/1.73m2, chronic diarrhea states; intake of thiazide diuretics, glucocorticoids, or estrogens within one month of the study
1
[ "Exclusion", "criteria", "for", "calcium", "stone", "formers", "include", ":", "primary", "or", "secondary", "hyperparathyroidism", ",", "hyperthyroidism", ",", "estimated", "GFR", "<", "40", "ml/mn/1.73m2", ",", "chronic", "diarrhea", "states", ";", "intake", "of", "thiazide", "diuretics", ",", "glucocorticoids", ",", "or", "estrogens", "within", "one", "month", "of", "the", "study" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 0, 2, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 1, 1, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0 ]
NCT01959698
1:19:chronic_disease,
Myocardial infarct within 6 months before enrollment
1
[ "Myocardial", "infarct", "within", "6", "months", "before", "enrollment" ]
[ 2, 2, 0, 0, 0, 0, 0 ]
NCT01714596
100:129:chronic_disease
Patients likely to have severe problems maintaining follow-up, including patients diagnosed with a severe psychiatric conditions, patients who live too far outside the hospital's catchment area
1
[ "Patients", "likely", "to", "have", "severe", "problems", "maintaining", "follow-up", ",", "including", "patients", "diagnosed", "with", "a", "severe", "psychiatric", "conditions", ",", "patients", "who", "live", "too", "far", "outside", "the", "hospital", "'s", "catchment", "area" ]
[ 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02382549
61:71:treatment,
Participants who have received the following medications or treatments at any time within 4 weeks of registration
1
[ "Participants", "who", "have", "received", "the", "following", "medications", "or", "treatments", "at", "any", "time", "within", "4", "weeks", "of", "registration" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02578732
14:22:chronic_disease
Uncontrolled diabetes. If patient has diabetes, confirmation on status (controlled or uncontrolled) required at registration
1
[ "Uncontrolled", "diabetes", ".", "If", "patient", "has", "diabetes", ",", "confirmation", "on", "status", "(", "controlled", "or", "uncontrolled", ")", "required", "at", "registration" ]
[ 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02579967
15:49:chronic_disease,53:83:chronic_disease,109:117:cancer,165:189:chronic_disease
Patients with hemophagocytic lymphohistiocytosis or macrophage activation syndrome related to an underlying lymphoma with no other clinical history suggestive of a primary immunodeficiency
1
[ "Patients", "with", "hemophagocytic", "lymphohistiocytosis", "or", "macrophage", "activation", "syndrome", "related", "to", "an", "underlying", "lymphoma", "with", "no", "other", "clinical", "history", "suggestive", "of", "a", "primary", "immunodeficiency" ]
[ 0, 0, 2, 2, 0, 2, 2, 2, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2 ]
NCT02719847
10:20:cancer
Patients malignancy is consistent with well differentiated neuroendocrine (carcinoid) histology
1
[ "Patients", "malignancy", "is", "consistent", "with", "well", "differentiated", "neuroendocrine", "(", "carcinoid", ")", "histology" ]
[ 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02048722
1:6:cancer
Tumor deemed unresectable or metastatic
1
[ "Tumor", "deemed", "unresectable", "or", "metastatic" ]
[ 3, 0, 0, 0, 0 ]
NCT02324582
1:26:treatment,
Prior monoclonal antibody within 4 weeks prior to study
1
[ "Prior", "monoclonal", "antibody", "within", "4", "weeks", "prior", "to", "study" ]
[ 1, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT01652092
14:48:chronic_disease
Other severe Combined Immune Deficiencies (CID)
1
[ "Other", "severe", "Combined", "Immune", "Deficiencies", "(", "CID", ")" ]
[ 0, 0, 2, 2, 2, 2, 0, 0 ]
NCT02778282
21:44:treatment
Seeking to initiate buprenorphine treatment or currently receiving buprenorphine treatment but had recent positive illicit opioid urine toxicology or missed scheduled urine toxicology
1
[ "Seeking", "to", "initiate", "buprenorphine", "treatment", "or", "currently", "receiving", "buprenorphine", "treatment", "but", "had", "recent", "positive", "illicit", "opioid", "urine", "toxicology", "or", "missed", "scheduled", "urine", "toxicology" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02514083
7:17:cancer
Prior malignancy
1
[ "Prior", "malignancy" ]
[ 0, 3 ]
NCT02048852
54:66:treatment,68:76:treatment,78:92:treatment,97:112:treatment,121:128:treatment,132:141:treatment
not using an acceptable form of birthcontrol such as Depo-provera, Norplant, tubal ligation and barrier methods such as condoms or diaphragm
1
[ "not", "using", "an", "acceptable", "form", "of", "birthcontrol", "such", "as", "Depo-provera", ",", "Norplant", ",", "tubal", "ligation", "and", "barrier", "methods", "such", "as", "condoms", "or", "diaphragm" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 1, 0, 1, 1, 0, 0, 1, 0, 1 ]
NCT00715611
32:47:chronic_disease
Patients with serious unstable medical illness
1
[ "Patients", "with", "serious", "unstable", "medical", "illness" ]
[ 0, 0, 0, 0, 2, 2 ]
NCT01356290
,,,,,,,,,,304:313:treatment,319:328:treatment,333:349:treatment
Participants must have normal organ and bone marrow function (ALT <5x institutional upper limit of normal, creatinine <1.5x institutional upper limit of normal for age, WBC >1000/mm3, platelets > 20,000/mm3. Patients with values less than WBC 2000/mm3 or platelets 50,000/mm3 will require initiation of treatment with etoposide and cyclophosphamide at a lower starting dose as defined within the protocol
1
[ "Participants", "must", "have", "normal", "organ", "and", "bone", "marrow", "function", "(", "ALT", "<", "5x", "institutional", "upper", "limit", "of", "normal", ",", "creatinine", "<", "1.5x", "institutional", "upper", "limit", "of", "normal", "for", "age", ",", "WBC", ">", "1000/mm3", ",", "platelets", ">", "20,000/mm3", ".", "Patients", "with", "values", "less", "than", "WBC", "2000/mm3", "or", "platelets", "50,000/mm3", "will", "require", "initiation", "of", "treatment", "with", "etoposide", "and", "cyclophosphamide", "at", "a", "lower", "starting", "dose", "as", "defined", "within", "the", "protocol" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03179449
27:38:allergy_name
Known hypersensitivity to ferumoxytol or any of its components
1
[ "Known", "hypersensitivity", "to", "ferumoxytol", "or", "any", "of", "its", "components" ]
[ 0, 0, 0, 4, 0, 0, 0, 0, 0 ]
NCT02484404
,29:62:treatment
within 6 weeks prior to the first dose of the study treatment are not eligible
1
[ "within", "6", "weeks", "prior", "to", "the", "first", "dose", "of", "the", "study", "treatment", "are", "not", "eligible" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 0, 0, 0 ]
NCT01360606
1:31:treatment,35:62:treatment,72:79:treatment,81:105:treatment,107:124:treatment,126:149:treatment,151:181:treatment,185:197:treatment,287:300:treatment,,390:399:treatment,461:465:treatment,521:537:treatment,
Previous systemic chemotherapy or non-radiation local therapy (such as surgery, hepatic arterial therapy, chemoembolization, radiofrequency ablation, percutaneous ethanol injection or cryoablation) is allowed. The lesion must however have shown criteria of progression based on RECIST. Local therapy must be completed at least 4 weeks prior to the baseline scan. This is to create a safer treatment environment and to help determine the effect of treatment by SBRT alone. Patients will be allowed to go onto appropriate systemic therapy, as determined by their medical oncologist, 2 weeks following delivery of SBRT
1
[ "Previous", "systemic", "chemotherapy", "or", "non-radiation", "local", "therapy", "(", "such", "as", "surgery", ",", "hepatic", "arterial", "therapy", ",", "chemoembolization", ",", "radiofrequency", "ablation", ",", "percutaneous", "ethanol", "injection", "or", "cryoablation", ")", "is", "allowed", ".", "The", "lesion", "must", "however", "have", "shown", "criteria", "of", "progression", "based", "on", "RECIST", ".", "Local", "therapy", "must", "be", "completed", "at", "least", "4", "weeks", "prior", "to", "the", "baseline", "scan", ".", "This", "is", "to", "create", "a", "safer", "treatment", "environment", "and", "to", "help", "determine", "the", "effect", "of", "treatment", "by", "SBRT", "alone", ".", "Patients", "will", "be", "allowed", "to", "go", "onto", "appropriate", "systemic", "therapy", ",", "as", "determined", "by", "their", "medical", "oncologist", ",", "2", "weeks", "following", "delivery", "of", "SBRT" ]
[ 1, 1, 1, 0, 1, 1, 1, 0, 0, 0, 1, 0, 1, 1, 1, 0, 1, 0, 1, 1, 0, 1, 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02143050
,,70:79:treatment,
Fertile males should use an effective method of contraception during treatment and for at least 3 months after completion of treatment, as directed by their physician
1
[ "Fertile", "males", "should", "use", "an", "effective", "method", "of", "contraception", "during", "treatment", "and", "for", "at", "least", "3", "months", "after", "completion", "of", "treatment", ",", "as", "directed", "by", "their", "physician" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02514083
1:37:treatment,39:51:treatment,53:65:treatment,69:89:treatment
Concomitant immunomodulatory therapy, chemotherapy, radiotherapy or experimental therapy
1
[ "Concomitant", "immunomodulatory", "therapy", ",", "chemotherapy", ",", "radiotherapy", "or", "experimental", "therapy" ]
[ 1, 1, 1, 0, 1, 0, 1, 0, 1, 1 ]
NCT02933034
12:22:chronic_disease
develop an arrhythmia prior to or during either of the exercise tests; SeeMore should not be administered
1
[ "develop", "an", "arrhythmia", "prior", "to", "or", "during", "either", "of", "the", "exercise", "tests", ";", "SeeMore", "should", "not", "be", "administered" ]
[ 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02423525
21:46:cancer,48:79:cancer,81:105:cancer,129:139:cancer,157:166:treatment,
effectively treated non-melanoma skin cancers, carcinoma in situ of the cervix, ductal carcinoma in situ or effectively treated malignancy that has been in remission for more than 3 years and is considered to be cured
1
[ "effectively", "treated", "non-melanoma", "skin", "cancers", ",", "carcinoma", "in", "situ", "of", "the", "cervix", ",", "ductal", "carcinoma", "in", "situ", "or", "effectively", "treated", "malignancy", "that", "has", "been", "in", "remission", "for", "more", "than", "3", "years", "and", "is", "considered", "to", "be", "cured" ]
[ 0, 0, 3, 3, 3, 0, 3, 3, 3, 3, 3, 3, 0, 3, 3, 3, 3, 0, 0, 0, 3, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02563678
19:37:treatment,
Prior work in the hyperbaric chamber in the last 72 hours
1
[ "Prior", "work", "in", "the", "hyperbaric", "chamber", "in", "the", "last", "72", "hours" ]
[ 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0 ]
NCT03114891
64:67:treatment,69:79:treatment,81:95:treatment,97:104:treatment
Medication use that substantially reduces seizure threshold to TMS (olanzapine, chlorpromazine, lithium)
1
[ "Medication", "use", "that", "substantially", "reduces", "seizure", "threshold", "to", "TMS", "(", "olanzapine", ",", "chlorpromazine", ",", "lithium", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0, 1, 0 ]
NCT03169543
12:28:chronic_disease,30:38:chronic_disease,40:48:chronic_disease,50:67:chronic_disease,69:82:chronic_disease,93:112:chronic_disease
History of bipolar disorder, delirium, dementia, amnestic disorder, schizophrenia and other psychotic disorders
1
[ "History", "of", "bipolar", "disorder", ",", "delirium", ",", "dementia", ",", "amnestic", "disorder", ",", "schizophrenia", "and", "other", "psychotic", "disorders" ]
[ 0, 0, 2, 2, 0, 2, 0, 2, 0, 2, 2, 0, 2, 0, 0, 2, 2 ]
NCT02053792
1:8:treatment
Surgery substudy
1
[ "Surgery", "substudy" ]
[ 1, 0 ]
NCT02929069
1:4:chronic_disease
HIV-positive status
1
[ "HIV-positive", "status" ]
[ 2, 0 ]
NCT02473536
28:46:chronic_disease
Subjects with a history of pulmonary embolism is excluded
1
[ "Subjects", "with", "a", "history", "of", "pulmonary", "embolism", "is", "excluded" ]
[ 0, 0, 0, 0, 0, 2, 2, 0, 0 ]
NCT02427997
1:11:treatment
medication regime is likely to change during the course of the study
1
[ "medication", "regime", "is", "likely", "to", "change", "during", "the", "course", "of", "the", "study" ]
[ 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02464696
22:35:treatment
Contraindications to NIPPV therapy
1
[ "Contraindications", "to", "NIPPV", "therapy" ]
[ 0, 0, 1, 1 ]
NCT02573493
1:19:treatment,21:48:treatment,53:76:treatment,81:86:cancer
Prior chemotherapy, prior EGFR targeted therapy, or prior radiation therapy for HNSCC
1
[ "Prior", "chemotherapy", ",", "prior", "EGFR", "targeted", "therapy", ",", "or", "prior", "radiation", "therapy", "for", "HNSCC" ]
[ 1, 1, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 3 ]
NCT02826343
12:38:chronic_disease,41:47:chronic_disease,73:85:chronic_disease
History of myocardial infarction (MI) , stroke and/or poorly controlled hypertension
1
[ "History", "of", "myocardial", "infarction", "(", "MI", ")", ",", "stroke", "and/or", "poorly", "controlled", "hypertension" ]
[ 0, 0, 2, 2, 2, 0, 0, 0, 2, 0, 0, 0, 2 ]
NCT02384954
5:8:chronic_disease
Not HIV positive
1
[ "Not", "HIV", "positive" ]
[ 0, 2, 0 ]
NCT03188042
1:24:chronic_disease,81:89:chronic_disease,91:97:chronic_disease
End-stage organ disease or medical condition with subsequent vision loss (e.g., diabetes, stroke)
1
[ "End-stage", "organ", "disease", "or", "medical", "condition", "with", "subsequent", "vision", "loss", "(", "e.g.", ",", "diabetes", ",", "stroke", ")" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 2, 0 ]
NCT02494869
1:11:chronic_disease
Thrombosis of lower extremities
1
[ "Thrombosis", "of", "lower", "extremities" ]
[ 2, 0, 0, 0 ]
NCT02344355
,102:125:cancer
Patients must have newly diagnosed (i.e., within 5 weeks), histologically or cytologically confirmed glioblastoma multiforme
1
[ "Patients", "must", "have", "newly", "diagnosed", "(", "i.e.", ",", "within", "5", "weeks", ")", ",", "histologically", "or", "cytologically", "confirmed", "glioblastoma", "multiforme" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3 ]
NCT02341963
12:20:allergy_name
Allergy to ketamine
1
[ "Allergy", "to", "ketamine" ]
[ 0, 0, 4 ]
NCT02593123
1:8:chronic_disease,10:23:chronic_disease,28:44:chronic_disease
Medical, psychological, or social condition that, in the opinion of the investigator, may increase the patient's risk or limit the patient's adherence with study requirements
1
[ "Medical", ",", "psychological", ",", "or", "social", "condition", "that", ",", "in", "the", "opinion", "of", "the", "investigator", ",", "may", "increase", "the", "patient", "'s", "risk", "or", "limit", "the", "patient", "'s", "adherence", "with", "study", "requirements" ]
[ 2, 0, 2, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03169543
9:19:chronic_disease
Current depression as assessed on the HDRS-17 (for depressed group only)
1
[ "Current", "depression", "as", "assessed", "on", "the", "HDRS-17", "(", "for", "depressed", "group", "only", ")" ]
[ 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01742299
,32:63:treatment,80:92:treatment,,151:160:treatment
Female sterilization (have had surgical bilateral oophorectomy with or without hysterectomy) or tubal ligation at least six weeks before taking study treatment
1
[ "Female", "sterilization", "(", "have", "had", "surgical", "bilateral", "oophorectomy", "with", "or", "without", "hysterectomy", ")", "or", "tubal", "ligation", "at", "least", "six", "weeks", "before", "taking", "study", "treatment" ]
[ 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT03070184
1:14:chronic_disease,,
Renal disease (eGFR < 60ml/min/1.73m2)
1
[ "Renal", "disease", "(", "eGFR", "<", "60ml/min/1.73m2", ")" ]
[ 2, 2, 0, 0, 0, 0, 0 ]
NCT02393794
44:81:treatment,83:97:treatment,99:114:treatment,116:131:treatment,133:149:treatment
Subject has previously been treated with a Histone deacetylases (HDAC) inhibitor, PD-1 inhibitor, PD-L1 inhibitor, PD-L2 inhibitor, CTLA-4 inhibitor
1
[ "Subject", "has", "previously", "been", "treated", "with", "a", "Histone", "deacetylases", "(", "HDAC", ")", "inhibitor", ",", "PD-1", "inhibitor", ",", "PD-L1", "inhibitor", ",", "PD-L2", "inhibitor", ",", "CTLA-4", "inhibitor" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 1, 1, 0, 1, 1, 0, 1, 1, 0, 1, 1 ]
NCT02806570
54:93:treatment,97:145:treatment,150:188:treatment
Implant or revision of any rhythm management device (cardiac resynchronization therapy (CRT) or cardiac resynchronization therapy device (CRT-D)) or implantable cardioverter defibrillator within the prior month
1
[ "Implant", "or", "revision", "of", "any", "rhythm", "management", "device", "(", "cardiac", "resynchronization", "therapy", "(", "CRT", ")", "or", "cardiac", "resynchronization", "therapy", "device", "(", "CRT-D", ")", ")", "or", "implantable", "cardioverter", "defibrillator", "within", "the", "prior", "month" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0 ]
NCT02585973
4:13:treatment
Co-treatment with weak inhibitors of CYP3A4
1
[ "Co-treatment", "with", "weak", "inhibitors", "of", "CYP3A4" ]
[ 1, 0, 0, 0, 0, 0 ]
NCT02008656
4:34:treatment
No prior pelvic radiation therapy
1
[ "No", "prior", "pelvic", "radiation", "therapy" ]
[ 0, 1, 1, 1, 1 ]
NCT02159703
7:19:treatment,
Prior chemotherapy within the past 5 years
1
[ "Prior", "chemotherapy", "within", "the", "past", "5", "years" ]
[ 0, 1, 0, 0, 0, 0, 0 ]
NCT02502253
87:97:treatment
Deemed too unstable medically or neurologically to safely enroll in trial of research medication
1
[ "Deemed", "too", "unstable", "medically", "or", "neurologically", "to", "safely", "enroll", "in", "trial", "of", "research", "medication" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02366481
37:51:treatment,
Subjects who have participated in a clinical study more recently than one month before the current study
1
[ "Subjects", "who", "have", "participated", "in", "a", "clinical", "study", "more", "recently", "than", "one", "month", "before", "the", "current", "study" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03149549
11:35:chronic_disease
Active or chronic corneal disorder
1
[ "Active", "or", "chronic", "corneal", "disorder" ]
[ 0, 0, 2, 2, 2 ]
NCT02576444
103:112:treatment
Patient must not have a co-morbid condition(s) that, in the opinion of the investigator, prevent safe treatment
1
[ "Patient", "must", "not", "have", "a", "co-morbid", "condition", "(", "s", ")", "that", ",", "in", "the", "opinion", "of", "the", "investigator", ",", "prevent", "safe", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02214667
1:20:chronic_disease
delusional disorder
1
[ "delusional", "disorder" ]
[ 2, 2 ]
NCT02895945
8:44:chronic_disease,,
Severe chronic liver dysfunction or disease (e.g., ≥ 5 × upper limit of normal [ULN] alanine aminotransferase [ALT], as confirmed by central laboratory at screening
1
[ "Severe", "chronic", "liver", "dysfunction", "or", "disease", "(", "e.g.", ",", "≥", "5", "×", "upper", "limit", "of", "normal", "[", "ULN", "]", "alanine", "aminotransferase", "[", "ALT", "]", ",", "as", "confirmed", "by", "central", "laboratory", "at", "screening" ]
[ 0, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03016130
30:34:treatment
Underlying diagnosis for non-HSCT patients
1
[ "Underlying", "diagnosis", "for", "non-HSCT", "patients" ]
[ 0, 0, 0, 1, 0 ]
NCT02512926
1:25:treatment
Myelosuppressive therapy
1
[ "Myelosuppressive", "therapy" ]
[ 1, 1 ]
NCT01570998
1:25:treatment
prior in-field radiation
1
[ "prior", "in-field", "radiation" ]
[ 1, 1, 1 ]
NCT00875342
8:26:treatment,39:64:treatment,66:81:treatment,86:112:treatment
Taking oral anticoagulant medication, ethionamide (Trecator-SC), isoniazid (INH), or anti-depressant medication
1
[ "Taking", "oral", "anticoagulant", "medication", ",", "ethionamide", "(", "Trecator-SC", ")", ",", "isoniazid", "(", "INH", ")", ",", "or", "anti-depressant", "medication" ]
[ 0, 1, 1, 0, 0, 1, 1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 1, 1 ]
NCT02945800
36:48:cancer,50:63:cancer,68:84:cancer,92:128:cancer
have had a histologic diagnosis of osteosarcoma, Ewing sarcoma, or rhabdomyosarcoma or non-rhabdomyosarcoma soft tissue sarcoma either at diagnosis or relapse
1
[ "have", "had", "a", "histologic", "diagnosis", "of", "osteosarcoma", ",", "Ewing", "sarcoma", ",", "or", "rhabdomyosarcoma", "or", "non-rhabdomyosarcoma", "soft", "tissue", "sarcoma", "either", "at", "diagnosis", "or", "relapse" ]
[ 0, 0, 0, 0, 0, 0, 3, 0, 3, 3, 0, 0, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0 ]
NCT02535923
61:70:treatment
Sufficient clinical stability to participate as deemed by a treatment provider
1
[ "Sufficient", "clinical", "stability", "to", "participate", "as", "deemed", "by", "a", "treatment", "provider" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
NCT02111850
58:94:allergy_name
History of severe immediate hypersensitivity reaction to any of the agents used in this study
1
[ "History", "of", "severe", "immediate", "hypersensitivity", "reaction", "to", "any", "of", "the", "agents", "used", "in", "this", "study" ]
[ 0, 0, 0, 0, 0, 0, 0, 4, 4, 4, 4, 4, 4, 4, 4 ]
NCT02048371
52:63:cancer
Patients with documentation of well differentiated liposarcoma only (of the well differentiated/dedifferentiated liposarcoma family) are specifically excluded, owing to its characteristically slow growth
1
[ "Patients", "with", "documentation", "of", "well", "differentiated", "liposarcoma", "only", "(", "of", "the", "well", "differentiated/dedifferentiated", "liposarcoma", "family", ")", "are", "specifically", "excluded", ",", "owing", "to", "its", "characteristically", "slow", "growth" ]
[ 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01389024
19:43:chronic_disease
Other significant organ system dysfunction
1
[ "Other", "significant", "organ", "system", "dysfunction" ]
[ 0, 0, 2, 2, 2 ]
NCT02724540
22:49:treatment
Contraindications to hepatic artery embolization
1
[ "Contraindications", "to", "hepatic", "artery", "embolization" ]
[ 0, 0, 1, 1, 1 ]
NCT02122081
31:65:chronic_disease
Patients seropositive for the human immunodeficiency virus (HIV)
1
[ "Patients", "seropositive", "for", "the", "human", "immunodeficiency", "virus", "(", "HIV", ")" ]
[ 0, 0, 0, 0, 2, 2, 2, 2, 0, 0 ]
NCT02960555
1:21:cancer
Plasma cell leukemia
1
[ "Plasma", "cell", "leukemia" ]
[ 3, 3, 3 ]
NCT01917929
15:55:chronic_disease
Patient has a neuromuscular or neurosensory deficiency that would create an unacceptable risk of instability, prosthesis fixation failure or complications in postoperative care, or which limits the ability to evaluate the safety and efficacy of the device
1
[ "Patient", "has", "a", "neuromuscular", "or", "neurosensory", "deficiency", "that", "would", "create", "an", "unacceptable", "risk", "of", "instability", ",", "prosthesis", "fixation", "failure", "or", "complications", "in", "postoperative", "care", ",", "or", "which", "limits", "the", "ability", "to", "evaluate", "the", "safety", "and", "efficacy", "of", "the", "device" ]
[ 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03144206
1:17:chronic_disease,83:92:treatment,109:136:chronic_disease,161:181:chronic_disease
Vascular disease resulting in clinically apparent compromise in blood flow to the treatment extremity (i.e. peripheral vascular disease with diminished pulses, venous insufficiency with clinical evidence of vascular congestion)
1
[ "Vascular", "disease", "resulting", "in", "clinically", "apparent", "compromise", "in", "blood", "flow", "to", "the", "treatment", "extremity", "(", "i.e", ".", "peripheral", "vascular", "disease", "with", "diminished", "pulses", ",", "venous", "insufficiency", "with", "clinical", "evidence", "of", "vascular", "congestion", ")" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02451982
1:22:chronic_disease
Stage I or II disease
1
[ "Stage", "I", "or", "II", "disease" ]
[ 2, 2, 2, 2, 2 ]
NCT02670837
5:31:treatment
Off immune suppressive therapy
1
[ "Off", "immune", "suppressive", "therapy" ]
[ 0, 1, 1, 1 ]
NCT02004275
65:74:treatment
Previous hypersensitivity to any of the components of the study treatment
1
[ "Previous", "hypersensitivity", "to", "any", "of", "the", "components", "of", "the", "study", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT01648023
28:50:treatment,63:73:treatment,75:86:treatment,91:100:treatment
Patients who have received prior systemic therapy with either irinotecan, gemcitabine, or cisplatin
1
[ "Patients", "who", "have", "received", "prior", "systemic", "therapy", "with", "either", "irinotecan", ",", "gemcitabine", ",", "or", "cisplatin" ]
[ 0, 0, 0, 0, 1, 1, 1, 0, 0, 1, 0, 1, 0, 0, 1 ]
NCT02264678
17:24:allergy_name
Bad reaction to AZD6738
1
[ "Bad", "reaction", "to", "AZD6738" ]
[ 0, 0, 0, 4 ]
NCT02101736
21:33:treatment,
No myelosuppressive chemotherapy within 4 weeks of study entry
1
[ "No", "myelosuppressive", "chemotherapy", "within", "4", "weeks", "of", "study", "entry" ]
[ 0, 0, 1, 0, 0, 0, 0, 0, 0 ]
NCT01925131
1:22:treatment,
Monoclonal antibodies must not have been received for 1 week prior to registration
1
[ "Monoclonal", "antibodies", "must", "not", "have", "been", "received", "for", "1", "week", "prior", "to", "registration" ]
[ 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02582827
,,,,,241:267:treatment,
QTc prolongation defined as a QTc interval according to Bazett's formula of ≥ 450 msec for male patients or ≥470 msec for female patients at Baseline. Interval determination will be based on a mean value obtained from 3 sequential baseline electrocardiographs (ECGs) obtained at least 5 minutes apart
1
[ "QTc", "prolongation", "defined", "as", "a", "QTc", "interval", "according", "to", "Bazett", "'s", "formula", "of", "≥", "450", "msec", "for", "male", "patients", "or", "≥470", "msec", "for", "female", "patients", "at", "Baseline", ".", "Interval", "determination", "will", "be", "based", "on", "a", "mean", "value", "obtained", "from", "3", "sequential", "baseline", "electrocardiographs", "(", "ECGs", ")", "obtained", "at", "least", "5", "minutes", "apart" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]